| pubmed-article:20435242 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20435242 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
| pubmed-article:20435242 | lifeskim:mentions | umls-concept:C1556085 | lld:lifeskim |
| pubmed-article:20435242 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:20435242 | lifeskim:mentions | umls-concept:C0751967 | lld:lifeskim |
| pubmed-article:20435242 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:20435242 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:20435242 | pubmed:dateCreated | 2010-5-3 | lld:pubmed |
| pubmed-article:20435242 | pubmed:abstractText | This analysis compared the cost-effectiveness of interferon beta-1a (IFNbeta-1a) 44 microg SC with that of other available first-line treatments for relapsing-remitting multiple sclerosis (RRMS) from the German societal perspective in 2008. | lld:pubmed |
| pubmed-article:20435242 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20435242 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20435242 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20435242 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20435242 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20435242 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20435242 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20435242 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20435242 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20435242 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20435242 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:20435242 | pubmed:issn | 1879-114X | lld:pubmed |
| pubmed-article:20435242 | pubmed:author | pubmed-author:MittendorfTho... | lld:pubmed |
| pubmed-article:20435242 | pubmed:author | pubmed-author:NuijtenMarkM | lld:pubmed |
| pubmed-article:20435242 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20435242 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:20435242 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20435242 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20435242 | pubmed:pagination | 717-28 | lld:pubmed |
| pubmed-article:20435242 | pubmed:meshHeading | pubmed-meshheading:20435242... | lld:pubmed |
| pubmed-article:20435242 | pubmed:meshHeading | pubmed-meshheading:20435242... | lld:pubmed |
| pubmed-article:20435242 | pubmed:meshHeading | pubmed-meshheading:20435242... | lld:pubmed |
| pubmed-article:20435242 | pubmed:meshHeading | pubmed-meshheading:20435242... | lld:pubmed |
| pubmed-article:20435242 | pubmed:meshHeading | pubmed-meshheading:20435242... | lld:pubmed |
| pubmed-article:20435242 | pubmed:meshHeading | pubmed-meshheading:20435242... | lld:pubmed |
| pubmed-article:20435242 | pubmed:meshHeading | pubmed-meshheading:20435242... | lld:pubmed |
| pubmed-article:20435242 | pubmed:meshHeading | pubmed-meshheading:20435242... | lld:pubmed |
| pubmed-article:20435242 | pubmed:meshHeading | pubmed-meshheading:20435242... | lld:pubmed |
| pubmed-article:20435242 | pubmed:meshHeading | pubmed-meshheading:20435242... | lld:pubmed |
| pubmed-article:20435242 | pubmed:meshHeading | pubmed-meshheading:20435242... | lld:pubmed |
| pubmed-article:20435242 | pubmed:meshHeading | pubmed-meshheading:20435242... | lld:pubmed |
| pubmed-article:20435242 | pubmed:meshHeading | pubmed-meshheading:20435242... | lld:pubmed |
| pubmed-article:20435242 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20435242 | pubmed:articleTitle | A health-economic evaluation of disease-modifying drugs for the treatment of relapsing-remitting multiple sclerosis from the German societal perspective. | lld:pubmed |
| pubmed-article:20435242 | pubmed:affiliation | Ars Accessus Medica, Amsterdam, the Netherlands. nuijten@bmg.eur.nl | lld:pubmed |
| pubmed-article:20435242 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20435242 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
